Peter is the Director of Intelligence Hub at Angelini Ventures, based in Singapore. He brings over 25 years of experience applying data, machine learning and AI across pharmaceutical and life sciences organisations, including senior data and analytics leadership roles at Novartis, Danone, A*STAR, Eli Lilly and Merck.

At the Novartis Institute for Tropical Diseases he built the informatics platform supporting the development of the antimalarial candidates ganaplacide and cipargamin.

At A*STAR's Experimental Therapeutics Centre he built the informatics function behind ETC-159, which went on to become Singapore's national platform for drug discovery and development.

At Danone he transformed clinical operations into a global digital innovation centre delivering healthcare applications across 21 countries.

Peter has also co-founded a Singapore consumer health business and advised biotech and diagnostics companies including Prestige BioPharma and MiRXES. I

n his role at Angelini Ventures, he builds the data, AI and intelligence capability underpinning deal sourcing, investment analysis and portfolio company support, with a particular focus on extending the firm's reach across Asia.

Peter holds a PhD in Computational Biology from University College Dublin and is a certified AI Governance Professional (IAPP).